Clinical trials
Resistance clinical trials
Below are recruiting resistance clinical trials, each written for real people, not researchers. We’re tracking 1,200 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07093801Recruiting
Study of lutetium-177-PSMA-617 for advanced prostate cancer
This study is observing how well the treatment lutetium-177-PSMA-617 works in people with metastatic castration-resistant prostate cancer. It aims to gather real-world information about its effectiveness and safety.
Alessandria, ALAges 18–99 - NCT07045064Recruiting
Exercise during dialysis for heart health
This study compares two types of exercise (aerobic vs. resistance training) done during hemodialysis sessions, and looks at how they affect a blood test related to heart disease risk.
Cairo, Select StateAges 40–60 - NCT06600802Recruiting
Lu-PSMA treatment for advanced prostate cancer
This study tests a radioactive drug called Lu-PSMA-617 for men with advanced prostate cancer that has spread and is no longer responding to hormone therapy. The drug targets a protein on cancer cells to deliver radiation directly to the tumor.
Clermont-FerrandAges 18 years+ - NCT06944158Recruiting
Antimicrobial resistance study for healthcare workers
This study asks healthcare workers to fill out a simple questionnaire to help understand how antibiotic resistance spreads. It aims to find ways to better protect patients and staff.
AleppoAges 25–65 - NCT06321679Recruiting
Study of bone scans for advanced prostate cancer treatment
This trial is testing how well treatments for advanced prostate cancer that has spread to the bones can be seen on scans. It may help doctors find better ways to measure if the cancer is responding to treatment.
MilanAges 18 years+ - NCT06724393Enrolling by invitation
Blood Flow Restriction Exercise for Older Adults
This study tests whether low-intensity exercise with blood flow restriction (using special cuffs on your arms or legs) can improve strength and daily function in older adults. You join online classes from home and go to the campus three times for check-ups.
Montreal, QuebecAges 60 years+ - NCT06682221Enrolling by invitationPhase 3
Resistance training and supplement study for older adults
This study tests whether a resistance training program (like lifting weights) combined with a supplement can improve heart, lung, and metabolic health in older adults. The goal is to find ways to help seniors stay healthier and more active.
Anápolis, GoiásAges 60–85 - NCT07156045RecruitingEarly Phase 1
Study of donor NK cells targeting PSMA for advanced prostate cancer
This trial tests a new treatment using natural killer cells from a healthy donor that are designed to find and attack prostate cancer cells that have a protein called PSMA. It may help men with advanced prostate cancer that has stopped responding to hormone therapy.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07682051Enrolling by invitation
Resistance training for patellar tendon pain
This study tests whether resistance training can improve the health of the patellar tendon in people with patellar tendinopathy (pain at the knee cap). It may help you recover strength and reduce pain over time.
Graz, StyriaAges 18–50 - NCT06710288RecruitingPhase 2
Immune cell therapy plus chemo for platinum-resistant ovarian cancer
This trial tests a new combination therapy for advanced ovarian cancer that has stopped responding to platinum-based chemo. You will receive your own immune cells (M-CENK) boosted with an immune stimulator (N-803) plus chemotherapy (gemcitabine) to see if this helps fight the cancer.
El Segundo, CaliforniaAges 18–85 - NCT06001255RecruitingPhase 2
Testing HS-20093 for advanced prostate and other solid cancers
This trial is testing a new drug called HS-20093 for people with advanced prostate cancer or other solid tumors that have spread and stopped responding to standard treatments. The drug targets a protein on cancer cells to try to stop cancer growth.
BeijingAges 18 years+ - NCT06515795Recruiting
Simple exercises to lower blood pressure in resistant hypertension
This study tests two simple, low-effort exercises (like squeezing a ball or holding a gentle pose) to see if they can help lower blood pressure for people whose high blood pressure doesn’t respond well to medication. The goal is to offer a safe, easy way to improve heart health.
AveiroAges 40–75 - NCT06380738Recruiting
Real-world study of olaparib plus abiraterone for advanced prostate cancer
This trial is for people with advanced prostate cancer (mCRPC) who are already taking the combination of olaparib and abiraterone. It will look at how these two medicines work together in real-world practice.
AschaffenburgAges 18 years+ - NCT07298239RecruitingEarly Phase 1
CAR-NK cell therapy for advanced prostate cancer
This trial tests a new immune cell therapy (CAR-NK cells) made from a healthy donor's cells. It is designed to attack prostate cancer that has spread and become resistant to hormone therapy, especially if your cancer cells have the PSMA protein.
Beijing, 不限Ages 18 years+ - NCT07228598Recruiting
Biofilm on chest drains after surgery
This study looks at a thin layer of bacteria (called biofilm) that can form on chest drains after surgery. Researchers want to learn if this biofilm causes infections and which antibiotics might work best—so they can improve care for patients like you.
Samsun, SamsunAges 18 years+ - NCT07311694RecruitingPhase 3
Comparing a new treatment with standard drugs for advanced prostate cancer
This trial tests a new drug, HRS-4357, against standard treatments for men with a specific type of advanced prostate cancer that has spread and no longer responds to hormone therapy. It aims to see if the new drug works better.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06568562RecruitingPhase 2
XL092 for advanced prostate cancer after PSMA therapy
This trial tests a new oral drug, XL092, for men with metastatic castration-resistant prostate cancer that has progressed after PSMA-targeted radiation therapy (Lu-177 PSMA-617). It aims to see if the drug can slow down the cancer.
Salt Lake City, UtahAges 18 years+ - NCT07721766Recruiting
How muscle type affects strength training results
This study looks at how your muscle's natural energy use affects how well it grows with weight training. It may help you understand your own response to exercise.
Jyväskylä, Central FinlandAges 18–39 - NCT07378813Recruiting
Light vs. heavy weight training for Parkinson's disease
This study compares two types of weight training (lifting lighter weights versus heavier weights) in people with Parkinson's disease. It aims to see which approach best improves movement, strength, and daily function.
Coral Gables, FloridaAges 50–85 - NCT07344727Recruiting
Can haskap berries help you recover after heavy squats?
This study tests whether taking haskap berries (a type of superfruit) before and after intense squat workouts can speed up your recovery and reduce soreness.
Bozeman, MontanaAges 18–35 - NCT07127575Recruiting
Stress management study for college students
This trial tests a stress management program for college students. You will learn stress-reducing skills and use a heart rate monitor to see how your body responds.
West Lafayette, IndianaAges 18–30 - NCT07164443RecruitingPhase 3
Study comparing pasritamig to placebo for advanced prostate cancer
This trial tests a new drug called pasritamig against a placebo for people with advanced prostate cancer that has stopped responding to hormone therapy and chemotherapy. The goal is to see if pasritamig can help slow the cancer's growth.
La Jolla, CaliforniaAges 18 years+ - NCT07744334Recruiting
Exercise program for quarry workers with breathing problems
This study tests whether a program of aerobic and resistance exercises can help male quarry workers who have breathing problems caused by dust. The exercises may improve their lung function and overall fitness.
Minya, Minya GovernorateAges 30–40 - NCT07594106RecruitingPhase 1/Phase 2
New immunotherapy for advanced prostate or kidney cancer
This trial tests new experimental drugs (REGN15505 and REGN4336) designed to target and attack cancer cells in advanced prostate cancer or kidney cancer. These drugs work by boosting your immune system to recognize and destroy cancer, and may be combined with other approved immunotherapy drugs.
Goodyear, ArizonaAges 18 years+
Hear when a new Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for resistance?
- Yes. Clin2 currently lists 1,200 recruiting resistance studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a resistance trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a resistance trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.